Dr. Rangwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Medical Ctr
# 10
Durham, NC 27710Phone+1 919-681-2954
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
- Duke University HospitalResidency, Internal Medicine, 2005 - 2008
- University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
- NC State Medical License 2011 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma.Melissa Johnson, David Hong, Irene Braña, Patrick Schöffski, Vladimir Galvao
Investigational New Drugs. 2025-03-05 - First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.Nehal J Lakhani, Daphne Stewart, Debra L Richardson, Lauren E Dockery, Linda Van Le
Journal for Immunotherapy of Cancer. 2025-01-11 - 10 citationsLIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.Kyung Jin Yoo, Kellsey Johannes, Louis E González, Arpita Patel, Casey W Shuptrine
Journal of Immunology. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: